We are international
Donate
• videos TEXT SIZE   
webcasts from medical meetings

Eastern Cooperative Oncology Group Clinical Trial:E1A05
Randomized Phase III Trial of Consolidation Therapy with Bortezomib (Velcade®) & Lenalidomide (Revlimid®) - Dexamethasone (VRD) versus Bortezomib (Velcade®:) - Dexamethasone (VD) for Patients With Multiple Myeloma Who Have Completed a Dexamethasone Based Induction Regimen
11.20.07
The Mayo Clinic's Dr. Rafael Fonseca, principal investigator, explains the E1A05 trial.


 related articles